Form 4: DENTSPLY SIRONA Director Acquires RSU Dividends

DENTSPLY SIRONA Inc. Director Leslie F. Varon acquired 198.141 additional restricted stock units as dividend equivalents, increasing her beneficial ownership.

Summary

• Leslie F. Varon, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 198.141 shares of Common Stock on January 9, 2026.
• The acquisition was for $0 per share, indicating it was not a purchase but an award.
• These shares represent dividends on previously awarded restricted stock units (RSUs), issued in the form of additional RSUs.
• The newly acquired RSUs are subject to the same vesting terms as the underlying awards, and the dividends vest simultaneously with the related RSUs.
• Each RSU converts to common stock on a 1:1 basis.
• Following this transaction, Leslie F. Varon beneficially owns a total of 57,541.066 shares of Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While a routine transaction, the increase in a director's beneficial ownership through equity awards generally signals continued alignment of interests with shareholders. It does not, however, indicate any new operational or financial performance news.

Positives

• Increased beneficial ownership by a director, Leslie F. Varon, which aligns her interests further with shareholders.
• The acquisition of shares through RSU dividends is a routine part of director compensation, indicating continuity in compensation structure.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Management Comments

• The transaction reflects the company's standard practice of awarding restricted stock units and their associated dividend equivalents as part of director compensation.

Industry Context

This Form 4 filing details a routine insider transaction, specifically the acquisition of equity compensation by a director. Such transactions are common across all industries as a mechanism for aligning management and director interests with those of shareholders, particularly through restricted stock units and their dividend equivalents.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and the payment of dividend equivalents on these units is a standard practice in executive and director compensation across many publicly traded companies, particularly in the healthcare and medical device sectors where DENTSPLY SIRONA operates.
• This compensation structure is comparable to those seen at peers like Align Technology (ALGN) or Zimmer Biomet Holdings (ZBH), which also utilize equity-based awards to incentivize long-term performance and retention among their leadership.

Related Party Transactions

• The acquisition of restricted stock units by Leslie F. Varon, a Director, from DENTSPLY SIRONA Inc. constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director can be viewed positively as it further aligns management's interests with those of the shareholders, potentially encouraging long-term value creation.

Next Steps

• The acquired restricted stock units will vest according to the terms of the underlying awards, converting into common stock upon vesting.

Key Dates

Recommendation

This Form 4 filing reports a routine acquisition of restricted stock units by a director as part of their compensation plan. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The increased beneficial ownership by a director is generally a positive signal of alignment with shareholder interests, but it is not a material event to alter a fundamental investment thesis.

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Beneficial Ownership, Equity Compensation